ArticleBlood advances2022
Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations.
Open access · goldAbstract read
In one paragraph
Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 25 citations in OpenAlex.
- Chromosomal Deletion Involving ANKRD26 Leads to Expression of a Fusion Protein Responsible for ANKRD26-Related Thrombocytopenia.International journal of molecular sciences · 2025Article
- Article
- Progress in the Genetics of Myelodysplastic Syndromes with a Latin American Perspective.Genes · 2025Review
- Genetic predisposition to myelodysplastic syndrome: Genetic counseling and transplant implications.Seminars in hematology · 2024Review
- Prospective genetic germline evaluation in a consecutive group of adult patients aged <60 years with myelodysplastic syndromes.HemaSphere · 2024Article
- Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.Best practice & research. Clinical haematology · 2024Review
- Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene-Environment Interactions.Cancer discovery · 2024Article
- Special Issue "Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms".International journal of molecular sciences · 2024Article
- Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.Blood advances · 2023Article
- Stagnation in quality of next-generation sequencing assays for the diagnosis of hereditary hematopoietic malignancies.Journal of genetic counseling · 2023Article
- Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26.Blood · 2023Article
- Germline and somatic drivers in inherited hematologic malignancies.Frontiers in oncology · 2023Review
- Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy.Frontiers in oncology · 2023Review
- Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling-a Singaporean experience.Frontiers in oncology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 5 institutions in 3 countries.
Michael W DrazerSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.ORCID 0000-0002-8171-4106
Claire C HomanDepartment of Genetics and Molecular Pathology, SA Pathology, Adelaide, South Australia.
Kai YuNational Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD.
Marcela Cavalcante de Andrade SilvaHospital Universitário Prof Alberto Antunes/Universidade Federal de Alagoas, Maceio, Brazil.ORCID 0000-0001-8367-0090
Kelsey E McNeelySection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.ORCID 0000-0002-8255-6816
Matthew J PozsgaiSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
Maria G Acevedo-MendezSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
Jeremy P SegalDepartment of Pathology, University of Chicago, Chicago, IL.
Peng WangDepartment of Pathology, University of Chicago, Chicago, IL.
Jinghua FengCenter for Cancer Biology, SA Pathology and University of South Australia, Adelaide, South Australia.ORCID 0000-0001-6821-5401
Sarah L King-SmithDepartment of Genetics and Molecular Pathology, SA Pathology, Adelaide, South Australia.
Erika KimNational Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD.
Sophia KorotevSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.ORCID 0000-0001-8512-4712
David M LawrenceDepartment of Genetics and Molecular Pathology, SA Pathology, Adelaide, South Australia.ORCID 0000-0001-5464-5830
Andreas W SchreiberDepartment of Genetics and Molecular Pathology, SA Pathology, Adelaide, South Australia.ORCID 0000-0002-9081-3405
Christopher N HahnDepartment of Genetics and Molecular Pathology, SA Pathology, Adelaide, South Australia.ORCID 0000-0001-5105-2554
Hamish S ScottDepartment of Genetics and Molecular Pathology, SA Pathology, Adelaide, South Australia.ORCID 0000-0002-5813-631X
Raman SoodNational Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD.ORCID 0000-0001-5565-662X
NISC Comparative Sequencing Program
Elvira D R P VellosoService of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil; and.ORCID 0000-0002-9707-0579
Anna L BrownDepartment of Genetics and Molecular Pathology, SA Pathology, Adelaide, South Australia.ORCID 0000-0002-9023-0138
Paul P LiuNational Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD.ORCID 0000-0002-6779-025X
Lucy A GodleySection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
South Australia Pathology · AUUniversity of Chicago · USNational Institutes of Health · USUniversidade de São Paulo · BRUniversidade Federal de Alagoas · BR
Funding
Inter- and Intra-Species Comparative SequencingZIBHG000196 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI THOMAS, JAMES · 2009 to 2025
$177.6MGENETIC ANALYSIS OF ZEBRAFISH EMBRYO DEVELOPMENTZIAHG000102 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI LIU, PAUL · 2009 to 2025
$17.1MAbstract
PubMed holds no abstract for this paper.
Indexed as
Clonal HematopoiesisGerm-Line MutationGenetic Predisposition to DiseaseHumansIntercellular Signaling Peptides and ProteinsProto-Oncogene Proteins c-etsANKRD26 protein, humanIntercellular Signaling Peptides and ProteinsProto-Oncogene Proteins c-ets
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.